Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)

被引：0
|
作者：
Hideki Kato
Masaomi Nangaku
Hideki Hirakata
Takashi Wada
Terumasa Hayashi
Hiroshi Sato
Yasushi Yamazaki
Takao Masaki
Tatsuo Kagimura
Hiroyasu Yamamoto
Hiroki Hase
Masahiro Kamouchi
Enyu Imai
Kyoichi Mizuno
Manabu Iwasaki
Tadao Akizawa
Yoshiharu Tsubakihara
Shoichi Maruyama
Ichiei Narita
机构：
[1] The University of Tokyo Graduate School of Medicine,Division of Nephrology and Endocrinology
[2] Fukuoka Renal Clinic,Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences
[3] Kanazawa University,Department of Kidney Disease and Hypertension
[4] Osaka General Medical Centre,Division of Clinical Pharmacology and Therapeutics
[5] Tohoku University Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Sciences,Department of Nephrology and Rheumatology
[6] Kagawa Prefectural Central Hospital,Department of Nephrology
[7] Hiroshima University Hospital,Department of Internal Medicine
[8] Translational Research Informatics Center,Division of Nephrology
[9] Foundation Biomedical Research and Innovation,Department of Health Care Administration and Management, Graduate School of Medical Sciences
[10] Atsugi City Hospital,Nakayamadera Imai Clinic, Takarazuka, Hyogo, Department of Nephrology
[11] Toho University Ohashi Medical Center,Department of Computer and Information Science
[12] Kyushu University,Division of Nephrology, Department of Medicine
[13] Fujita Health University Toyoake,Course of Safety Management in Health Care Sciences, Graduate School of Health Care Sciences
[14] Mitsukoshi Health and Welfare Foundation,Department of Nephrology
[15] Seikei University,Division of Clinical Nephrology and Rheumatology
[16] Showa University School of Medicine,undefined
[17] Jikei Institute,undefined
[18] Nagoya University Graduate School of Medicine,undefined
[19] Niigata University Graduate School of Medical and Dental Sciences,undefined
来源：
Clinical and Experimental Nephrology | 2018年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：85 / 86
页数：1
相关论文
共 50 条
  • [31] Molidustat for Renal Anemia in Nondialysis Patients Previously Treated with Erythropoiesis-Stimulating Agents: A Randomized, Open-Label, Phase 3 Study
    Yamamoto, Hiroyasu
    Nobori, Kiyoshi
    Matsuda, Yoshimi
    Hayashi, Yasuhiro
    Hayasaki, Takanori
    Akizawa, Tadao
    AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (10-11) : 884 - 893
  • [32] CARDIOVASCULAR EVENTS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND ANEMIA: REGIONAL ANALYSIS OF PATIENTS PREVIOUSLY TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS IN THE PRO2TECT TRIAL
    Parfrey, Patrick
    Chertow, Glenn
    Eckardt, Kai-Uwe
    Burke, Steven
    Luo, Wenli
    Minga, Todd
    Winkelmayer, Wolfgang
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I386 - I387
  • [33] CARDIOVASCULAR EVENTS IN PATIENTS WITH ANEMIA ASSOCIATED WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE: REGIONAL ANALYSIS OF PATIENTS NOT PREVIOUSLY TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS IN THE PRO2TECT TRIAL
    Winkelmayer, Wolfgang
    Arnold, Susan
    Burke, Steven
    Chertow, Glenn
    Eckardt, Kai-Uwe
    Luo, Wenli
    Minga, Todd
    Parfrey, Patrick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I392 - I393
  • [34] Impact of anemia correction with an erythropoiesis stimulating protein (ESP) on renal function in chronic kidney disease (CKD) patients not on dialysis: A meta-analysis
    Lea, J
    Kawalramani, R
    Agodoa, I
    Nora, J
    Pinto, L
    Badamgarav, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A39 - A39
  • [35] Treatment of renal anaemia with erythropoiesis-stimulating agents in predialysis chronic kidney disease patients: Haemoglobin profile during the 6 months before initiation of dialysis
    Kawahara, Kazuhiko
    Minakuchi, Jun
    Yokota, Narushi
    Suekane, Hiroto
    Tsuchida, Kenji
    Kawashima, Shu
    NEPHROLOGY, 2015, 20 : 29 - 32
  • [36] Aranesp™ (darbepoetin alfa) administered once every other week treats anemia in patients with chronic kidney disease (CKD) not receiving renal replacement therapy.
    Toto, RD
    Navarro, J
    Roger, S
    Churchill, DN
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 635A - 635A
  • [37] A phase 3, open-label, single-arm study of vadadustat for anemia in chronic kidney disease for Japanese patients on hemodialysis not receiving erythropoiesis-stimulating agents
    Nangaku, Masaomi
    Kondo, Kazuoki
    Takabe, Souichirou
    Ueta, Kiichiro
    Tandai, Tsubasa
    Kawaguchi, Yutaka
    Komatsu, Yasuhiro
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (01) : 45 - 54
  • [38] SAFETY OF ROXADUSTAT VERSUS ERYTHROPOIESIS-STIMULATING AGENTS FOR TREATMENT OF ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE INCIDENT TO OR NOT RECEIVING DIALYSIS: POOLED ANALYSIS OF FOUR PHASE 3 STUDIES
    Barratt, Jonathan
    Dellanna, Frank
    Portoles, Jose
    Choukroun, Gabriel
    De Nicola, Luca
    Reusch, Michael
    Young, James
    Dimkovic, Nada
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I387 - I388
  • [39] TO INVESTIGATE THE EFFICACY AND SAFETY OF MOLIDUSTAT IN NON-DIALYSIS PATIENTS WITH RENAL ANEMIA WHO ARE NOT TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS: MIYABI ND-C
    Yamamoto, Hiroyasu
    Taguchi, Megumi
    Nobori, Kiyoshi
    Matsuda, Yoshimi
    Iekushi, Kazuma
    Akizawa, Tadao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2177 - 2177
  • [40] Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study
    Sinha, Shubhadeep D.
    Bandi, Vamsi K.
    Reddy, Bala B.
    Thakur, Pankaj
    Chary, Sreenivasa
    Talluri, Leela
    Kakkunnath, Sheejith
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
12345